Influence of antibiotics and silver nanoparticles on the change of sensitivity of E. coli to antibacterial drugs

Research has been conducted to evaluate the effect of antibiotics and silver nanoparticles in combination with antibiotics on the change in antibiotic sensitivity to antibacterial drugs of E. coli ATCC 25922 reference strain and its isolate. Nanoparticles obtained by electron beam treatment of aqueous solution containing water-soluble stabilizing polymer and water-soluble silver salt were used in the experiment. During the treatment a beam of accelerated electrons obtained on the installation of a linear accelerator of the ILU-10 type passed through a solution with a working dose of 5–30 kGy ranging in size from 20 to 60 nm. Sensitivity of microorganisms of E. coli ATCC 25922 reference strain and its isolate obtained from cow endometritis to antibacterial substances and their combinations was determined from dilution with a minimum bacteriostatic concentration. The dilution in the amount of 0.2 ml was added to meat-and-peptone agar and the antibiotic sensitivity of microorganisms was determined by the disk diffusion method. Sensitivity to 24 types of antibacterial drugs was tested. Cultivation of E. coli ATCC 25922 with AgNPs in combination with one of the antibiotics (azitronite, amoxicillin, enroflox, ceftiofur, tylosin, cobactan, oxytetracycline) contributed to an increase in the number of drugs (from 14.3 to 57.1%), to which the microorganism was sensitive. Cultivation of the E. coli isolate with 5 (62.5%) of the studied antibiotics led to an increase in resistance from 1 (5.5%) to 3 (16.7%) antibacterial agents. AgNPs in combination with antibiotics azitronite, amoxicillin, enroflox, ceftiofur, tylosin, cobactan, gentamicin, oxytetracycline contributed to a decrease in the resistance of E. coli ATCC 25922 (from 15.4 to 46.1%) and E. coli field isolate (from 16.7 to 37.7%) to antibacterial drugs. The pronounced ability of AgNPs to increase antibiotic sensitivity was established. This was confirmed by the joint cultivation of antibiotics and AgNPs with E. coli ATCC 25922 and field isolate of E. coli, causing an increase in sensitivity and high sensitivity to antibacterial drugs, which was previously absent. The study confirmed the results of research on the ability of nanoparticles of metals of the transition group to affect the sensitivity of microorganisms to antibacterial agents and to restore it.

1. Sidorenko S.V., Tishkov V.I. Molekulyarnye osnovy rezistentnosti k antibiotikam [Molecular basis of antibiotic resistance]. Uspekhi biologicheskoi khimii [Biological Chemistry Reviews], 2004, vol. 44, pp. 263–306.

2. Yuan Y.G., Peng Q.L., Gurunathan S. Effects of silver nanoparticles on multiple drug-resistant strains of staphylococcus aureus and pseudomonas aeruginosa from mastitis-infected goats: an alternative approach for antimicrobial therapy. International Journal of Molecular Sciences, 2017, mar 6, no. 18 (3), DOI: 10.3390/ijms18030569.

3. Yu L., Chen X., Shang F., Ni J. The anti-biofilm effect of silver-nanoparticle-decorated quercetin nanoparticles on a multi-drug resistant Escherichia coli strain isolated from a dairy cow with mastitis. Peer-reviewed Journals, 2018, oct 16; 6: e5711. DOI: 10.7717/peerj.5711.

4. Nesterov N. Kombikormovoi otrasl'yu mozhno gordit'sya [The feed industry can be proud of]. Zhivotnovodstvo Rossii [Animal Husbandry of Russia], 2014, no. 2, pp. 2–4. (In Russian).

5. Lozovoi D.A., Rakhmanov A.M. Sotrudnichestvo veterinarnykh sluzhb gosudarstv – uchastnikov SNG [Collaboration between veterinary services of CIS countries]. Veterinariya segodnya [Veterinary Science today], 2015, no. 2, pp. 8–10. (In Russian).

6. Nadworny P.L., Wang J., Tredget E.E. Anti-inflammatory activity of nanocrystalline silver in a porcine contact dermatitis model. Nanomedicine, 2008, no. 4, pp. 241–251.

7. Sibbald R.G., Contreras-Ruiz J., Coutts P. Bacteriology, inflammation, and healing: a study of nanocrystalline silver dressings in chronic venous leg ulcers. Advances in skin and wound care, 2007, no. 20, pp. 549–558.

8. Tian J., Wong K.K., Ho C.M. Lok C.N., Yu W.Y., Che C.M., Chiu J.F., Tam P.K. Topical delivery of silver nanoparticles promotes wound healing. Medicinal Chemistry Research, 2007, no. 2, pp. 129–136.

9. Yamanaka M., Hara K., Kudo J. Bactericidal actions of a silver ion solution on Escherichia coli, studied by energy-filtering transmission electron microscopy and proteomic analysis. Applied and Environmental Microbiology, 2005, no. 71, pp. 7589–7593.

10. Jung W.K., Koo H.C., Kim K.W. Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli. Applied and Environmental Microbiolog, 2008, no. 74, pp. 2171–2178.

11. Morones J.R., Elechiguerra J.L., Camacho A. The bactericidal effect of silver nanoparticles. Nanotechnology, 2005, no. 16, pp. 2346–2353.

12. Shrivastava S., Tanmay B., Arnab R. Characterization of enhanced antibacterial effects of novel silver nanoparticles. Nanotechnology, 2007, no. 18, pp. 225103–225112.

13. Yang W.J., Cenchao S., Zhizhou Z. Food storage material silver nanoparticles interfere with DNA replication fidelity and bind with DNA. Nanotechnology. 2009, no. 20, pp. 85–102.

14. Burda C., Chen X., Narayanan R., El-Sayed M.A. Chemistry and properties of nanocrystals of different shapes. Journal of Chemical Reviews. 2005, apr. 105 (4), pp. 1025–102.

15. Panacek A., Kvítek L., Prucek R., Kolar M., Vecerova R., Pizúrova N., Sharma V.K., Nevecna T., Zboril R. Silver colloid nanoparticles: synthesis, characterization, and their antibacterial activity. Journal of Physical Chemistry B, 2006, no. 110 (33), pp. 16248–16253.

16. Lok C.N., Ho C.M., Chen R., He Q.Y., Yu W.Y. Silver nanoparticles: partial oxidation and antibacterial activities. Journal of Biological Chemistry, 2007, no. 12, pp. 527–534.

17. Singh M., Kumar M., Kalaivani R., Manikandan S., Kumaraguru A.K. Metallic silver nanoparticle: a therapeutic agent in combination with antifungal drug against human fungal pathogen. Bioprocess and Biosystems Engineering, 2013, vol. 36, no. 4, pp. 407–415.

18. Panpaliya N.P., Dahake P.T., Kale Y.J., Dadpe M.V., Kendre S.B., Siddiqi A.G., Maggavi U.R In vitro evaluation of antimicrobial property of silver nanoparticles and chlorhexidine against five different oral pathogenic bacteria. Saudi Dental Journal, 2019, vol. 31 (1), pp. 76–83. DOI: 10.1016/j.sdentj.2018.10.004.

19. Gupta D., Singh A., Khan A.U. Nanoparticles as efflux pump and biofilm Inhibitor to rejuvenate bactericidal effect of conventional antibiotic. Saudi Dental Journal, 2017, no. 12 (1), pp. 454. DOI: 10.1186/s11671-017-2222-6.